PPT-Non-Opioid Medications for

Chronic Pain Family Medicine Wednesday School 21319 George D Comerci Jr MD FACP Professor of Internal Medicine University of New Mexico School of Medicine Medical Director Project ECHO Pain and Opioid Management Clinic. June 21, 2016 | Governor’s Planning Meeting. Reka Danko, M.D. . Chief Medical Officer|Director of MAT program, Northern Nevada HOPES. Hospitalist, Saint Mary’s Medical Center|Rosewood Rehabilitation. National Safety Council. Medical Provider. Mountain Area Recovery Center. Asheville, NC. Medical Provider. Meridian Behavioral Health Services. Waynesville, . NC. Masters student . UNC Gillings School of Global Public Heath. Tracy Brooks, . PharmD. , BCPS, BCNSP. Assistant Professor of Pharmacy Practice. Member of PRMC’s Palliative Care Team. Member of Indiana RX Task Force. Objectives:. Pharmacists:. Review the terms “legitimate medical purpose” and “corresponding responsibility” as they apply to the use of opioid analgesics in the treatment of chronic pain.. Introduction. Scope of the Problem. National Roadside Survey Results. PDI Medications. PDI Medications (cont). Drug-Related AEs. Benzodiazepines and Hypnotics. Melatonin vs Zolpidem. NSAIDs. Teens/Young Adults and Prescription Drugs. Stacie Levine MD. Coleman Foundation Winter Conference. February 28, 2014. Learning objectives. 1. Incorporate recent regulatory changes in regard to the prescription of opioid medications into practice. Improvement Protocol (TIP) 63:. Medications for Opioid Use Disorder . Name of Presenter . Position Title. Substance Abuse and Mental Health Services Administration . U.S. Department of Health and Human Services. Most painkiller use isn’t . misuse. Effective to treat residual pain after surgery, as well as chronic pain. Highly habit-forming . Deadly at high doses or in conjunction with other drugs. Pain Medications. Stacie Levine MD. Coleman Foundation Winter Conference. February 28, 2014. Learning objectives. 1. Incorporate recent regulatory changes in regard to the prescription of opioid medications into practice. Angeline Stanislaus, MD. Chief Medical director- adult services. Missouri . Dept. of Mental Health. How many people are dying each day?. 115. Overdoses. Missouri- Total number of opioid related death 2017. David Willey MD. Substance Use Unit Director. Cottonwood Springs Hospital. 1. Medications for . Original Presentation and multiple slides courtesy of:. Karen . Drexler, MD. Deputy National Mental Health Program Director- Addictive Disorders. MAT BASICS Peter Mason MD Medical Director Region 1 IDN Opioid Use Disorder (OUD) Opioid Use Disorder (OUD): A medical condition characterized by a problematic pattern of opioid use that causes clinically significant impairment or distress. (FORE), a private, national organizationfocused on contributing sustainable and scalable solutions to the opioid crisis, today announced that it is making$10million in grants toorganizations across th : . Addressing Fear and Discrimination (Part I). Sharon Morello RN, BSN . Opioid Epidemic and Substance Use Disorders. . Heroin use climbed then stabilized . See table 7.2 in the 2017 NSDUH detailed tables for additional information and the 2017 CDC Mortality Data.. In Head and Neck Endocrine Surgery: . An American Head and Neck Society . Endocrine Surgery Section Consensus Statement. JK Ferrell, ML Shindo, BC Stack, Jr., P Angelos, G Bloom, AY Chen, L Davies, JC Irish, T Kroeker, SD McCammon, .